Friday Jun 25, 2021

CMDA | Aducanumab

Dr. Lea Watson covers two drugs, Nuplazid and the new one  approved by the FDA, Aducanumab. Followed by Dr. Sing Palat, CMD and new President of CMDA who discusses the use of oxygen with nocturnal hypoxemia in COPD.

Recording Date: 5/6/2021

Available Credit

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright 2021 amda. All rights reserved.

Podcast Powered By Podbean